TC BioPharm slumps 36% after pricing $4M public offering
seekingalpha.com
finance
2022-06-03 09:16:59

sefa ozel/E+ via Getty Images 
 TC BioPharm (NASDAQ:TCBP) stock fell ~36% premarket June 3 after the company priced a public offering of 10M American Depositary Shares (ADSs) at $0.40 per ADS for gross proceeds of $4M.
The company announcement came in a post-market June 2 release.
Each ADS represents one ordinary share.
The company also granted the underwriters a 45-day option to buy up to an additional 1.5M ADSs at the offering price.
The offering is expected to close around June 7, subject to conditions.
